Virology. 2006 Apr 10;347(2):405-9. Epub 2006 Jan 20.

Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.

Source

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605-2324, USA.

Abstract

The selective pressure of the competitive protease inhibitors causes both HIV-1 protease and occasionally its substrates to evolve drug resistance. We hypothesize that this occurs particularly in substrates that protrude beyond the substrate envelope and contact residues that mutate in response to a particular protease inhibitor. To validate this hypothesis, we analyzed substrate and protease sequences for covariation. Using the chi2 test, we show a positive correlation between the nelfinavir-resistant D30N/N88D protease mutations and mutations at the p1-p6 cleavage site as compared to the other cleavage sites. Both nelfinavir and the substrate p1-p6 protrude beyond the substrate envelope and contact residue 30, thus possibly making the p1-p6 cleavage site more vulnerable to co-evolution.

PMID:: 16430939; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro. [J Virol. 2002]
Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro.
Maguire MF, Guinea R, Griffin P, Macmanus S, Elston RC, Wolfram J, Richards N, Hanlon MH, Porter DJ, Wrin T, et al. J Virol. 2002 Aug; 76(15):7398-406.
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. [J Virol. 1997]
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Zhang YM, Imamichi H, Imamichi T, Lane HC, Falloon J, Vasudevachari MB, Salzman NP. J Virol. 1997 Sep; 71(9):6662-70.
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance. [J Virol. 2009]
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
Kolli M, Stawiski E, Chappey C, Schiffer CA. J Virol. 2009 Nov; 83(21):11027-42. Epub 2009 Aug 12.
Review Design of tight-binding human immunodeficiency virus type 1 protease inhibitors. [Methods Enzymol. 1994]
Review Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.
Vacca JP. Methods Enzymol. 1994; 241:311-34.
Review Resistance to HIV protease inhibitors: mechanisms and clinical consequences. [Curr Drug Metab. 2004]
Review Resistance to HIV protease inhibitors: mechanisms and clinical consequences.
de Mendoza C, Soriano V. Curr Drug Metab. 2004 Aug; 5(4):321-8.

See reviews... See all...

Cited by 11 PubMed Central articles

Molecular Basis for Drug Resistance in HIV-1 Protease. [Viruses. 2010]
Molecular Basis for Drug Resistance in HIV-1 Protease.
Ali A, Bandaranayake RM, Cai Y, King NM, Kolli M, Mittal S, Murzycki JF, Nalam MN, Nalivaika EA, Ozen A, et al. Viruses. 2010 Nov; 2(11):2509-2535. Epub 2010 Nov 12.
Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen. [PLoS One. 2011]
Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen.
Ghosn J, Delaugerre C, Flandre P, Galimand J, Cohen-Codar I, Raffi F, Delfraissy JF, Rouzioux C, Chaix ML. PLoS One. 2011; 6(9):e24798. Epub 2011 Sep 20.
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir. [Antimicrob Agents Chemother. 2...]
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir.
Larrouy L, Lambert-Niclot S, Charpentier C, Fourati S, Visseaux B, Soulié C, Wirden M, Katlama C, Yeni P, Brun-Vézinet F, et al. Antimicrob Agents Chemother. 2011 Apr; 55(4):1754-7. Epub 2011 Jan 31.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
Virology. 2006 Apr 10 ;347(2):405-9. Epub 2006 Jan 20 .

PubMed
The effect of addressing demand for as well as supply of emergency obstetric car...
The effect of addressing demand for as well as supply of emergency obstetric care in Dinajpur, Bangladesh.
Int J Gynaecol Obstet. 2006 Mar ;92(3):320-8. Epub 2006 Jan 20 .

PubMed
Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Chem Biol Interact. 2006 Mar 10 ;160(1):1-40. Epub 2006 Jan 23 .

PubMed
Research of stimulants and anabolic steroids in dietary supplements.
Research of stimulants and anabolic steroids in dietary supplements.
Scand J Med Sci Sports. 2006 Feb ;16(1):41-8.

PubMed
Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA...
Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties.
Biochemistry. 1992 Aug 11 ;31(31):7104-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 11 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information